Financhill
Back

KalVista Pharmaceuticals Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.

KalVista Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 8.71 Buy
20-day SMA: 8.82 Buy
50-day SMA: 9.86 Sell
200-day SMA: 11.51 Sell
8-day EMA: 8.73 Buy
20-day EMA: 8.92 Buy
50-day EMA: 9.67 Sell
200-day EMA: 11.02 Sell

KalVista Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 48.94 Sell
Chaikin Money Flow: 3049 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.46 - 9.62) Sell
Bollinger Bands (100): (9.39 - 12.25) Sell

KalVista Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for KalVista Pharmaceuticals Stock

Is KalVista Pharmaceuticals Stock a Buy?

KALV Technical Analysis vs Fundamental Analysis

Sell
34
KalVista Pharmaceuticals (KALV) is a Sell

Is KalVista Pharmaceuticals a Buy or a Sell?

KalVista Pharmaceuticals Stock Info

Market Cap:
446.2M
Price in USD:
9.03
Share Volume:
152.4K

KalVista Pharmaceuticals 52-Week Range

52-Week High:
16.88
52-Week Low:
7.97
Sell
34
KalVista Pharmaceuticals (KALV) is a Sell

KalVista Pharmaceuticals Share Price Forecast

Is KalVista Pharmaceuticals Stock a Buy?

Fundamental Analysis of KalVista Pharmaceuticals

Is KalVista Pharmaceuticals a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.61 per share, and an increase next year of $1.01 per share.

Technical Analysis of KalVista Pharmaceuticals

Should I short KalVista Pharmaceuticals stock?

* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.